First Case of HIV Seroconversion With Integrase Resistance Mutations on Long-Acting Cabotegravir for Prevention in Routine Care.

MLA

Koss, Catherine A., et al. “First Case of HIV Seroconversion With Integrase Resistance Mutations on Long-Acting Cabotegravir for Prevention in Routine Care.” Open Forum Infectious Diseases, vol. 11, no. 9, Sept. 2024, pp. 1–7. EBSCOhost, https://doi.org/10.1093/ofid/ofae468.

APA

Koss, C. A., Gandhi, M., Halvas, E. K., Okochi, H., Chu, C., Glidden, D. V., Gomez, L. G., Heaps, A. L., Conroy, A. A., Tran, M., Shetler, C., Hoeth, D., Kuncze, K., Louie, A., Garza, H. R., Mugoma, E. W., Penrose, K. J., Chohan, B. H., Ayieko, J. O., & Mills, A. (2024). First Case of HIV Seroconversion With Integrase Resistance Mutations on Long-Acting Cabotegravir for Prevention in Routine Care. Open Forum Infectious Diseases, 11(9), 1–7. https://doi.org/10.1093/ofid/ofae468

Chicago

Koss, Catherine A, Monica Gandhi, Elias K Halvas, Hideaki Okochi, Carolyn Chu, David V Glidden, Lisa Georgetti Gomez, et al. 2024. “First Case of HIV Seroconversion With Integrase Resistance Mutations on Long-Acting Cabotegravir for Prevention in Routine Care.” Open Forum Infectious Diseases 11 (9): 1–7. doi:10.1093/ofid/ofae468.